NEW YORK (GenomeWeb) – Canadian molecular diagnostics firm Qvella announced today it has raised $20 million in Series A financing.

The funding round was co-led by RA Capital Management and Whitecap Venture Partners, and included Hatteras Venture Partners and Sands Capital Ventures as syndicate partners.

"This latest round of funding provides us with the capital to support our ongoing research and development, and build out our team," Tino Alavie, president, CEO, and co-founder of Toronto-based Qvella, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.